GlaxoSmithKline's OTC Garage Sale Includes alli, FiberChoice

GlaxoSmithKline includes the alli weight-loss brand in its planned divestment of international OTCs worth about $813 million in 2010 sales, or 10% of the firm's total Consumer Healthcare business.